Technical Analysis for MYX - Mayne Pharma Group Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -6.07% | |
| Fell Below 50 DMA | Bearish | -6.07% | |
| MACD Bearish Signal Line Cross | Bearish | -6.07% | |
| Down 3 Days in a Row | Weakness | -6.07% | |
| Fell Below 20 DMA | Bearish | -10.11% | |
| 50 DMA Support | Bullish | -10.11% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 14 hours ago |
| Fell Below Lower Bollinger Band | about 14 hours ago |
| 2x Volume Pace | about 16 hours ago |
| Down 1 ATR | about 18 hours ago |
| Down 5% | about 18 hours ago |
Get this analysis on your stocks daily!
Mayne Pharma Group Ltd Description
Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Manufacturing Pharmaceutical Pharmaceuticals Pharmaceutical Industry Pharmaceuticals Policy Drug Delivery Pharmaceutical Products Pharmaceutical Industry In China Contract Manufacturing Contract Services Pharmaceutical Companies Pharmaceutical Development Science And Technology In The People's Republic Of China Contract Manufacturing Services Generic Pharmaceutical Product Generic Pharmaceutical Products Manufacturing Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.46 |
| 52 Week Low | 3.74 |
| Average Volume | 164,888 |
| 200-Day Moving Average | 5.292 |
| 50-Day Moving Average | 4.616 |
| 20-Day Moving Average | 4.618 |
| 10-Day Moving Average | 4.822 |
| Average True Range | 0.265 |
| RSI (14) | 37.11 |
| ADX | 18.78 |
| +DI | 20.272 |
| -DI | 31.879 |
| Chandelier Exit (Long, 3 ATRs) | 4.625 |
| Chandelier Exit (Short, 3 ATRs) | 4.815 |
| Upper Bollinger Bands | 5.249 |
| Lower Bollinger Band | 3.987 |
| Percent B (%b) | 0.15 |
| BandWidth | 27.324 |
| MACD Line | -0.010 |
| MACD Signal Line | 0.041 |
| MACD Histogram | -0.0505 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.840 | ||||
| Resistance 3 (R3) | 4.860 | 4.660 | 4.730 | ||
| Resistance 2 (R2) | 4.660 | 4.492 | 4.650 | 4.693 | |
| Resistance 1 (R1) | 4.420 | 4.388 | 4.320 | 4.400 | 4.657 |
| Pivot Point | 4.220 | 4.220 | 4.170 | 4.210 | 4.220 |
| Support 1 (S1) | 3.980 | 4.052 | 3.880 | 3.960 | 3.703 |
| Support 2 (S2) | 3.780 | 3.948 | 3.770 | 3.667 | |
| Support 3 (S3) | 3.540 | 3.780 | 3.630 | ||
| Support 4 (S4) | 3.520 |
